Browsing Tag

Myelosuppression

COSELA® (Trilaciclib Hydrochloride for Injection) Now Approved in China to Decrease…

Eli Pacheco Jul 13, 2022 0

RESEARCH TRIANGLE PARK, N.C., July 13, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the China National Medical…

Health

New Real-World Data Show Potential of Trilaciclib to Reduce the Substantial Burden of…

Eli Pacheco Apr 1, 2022 0

RESEARCH TRIANGLE PARK, N.C., March 31, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced results of a retrospective,…

Health

Starton Therapeutics Announces Successful Results in STAR-LLD Toxicology Study: No…

Eli Pacheco Sep 30, 2021 0

PARAMUS, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc., a clinical stage biotechnology company transforming standard of care therapies with proprietary dermal…